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support life of people living with cancer, qualitatively and quantitatively which will be discussed in this paper.
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Introduction: Information have key role for effective decision making to quality nursing practice. Computer science, information
science, and nursing science combined to assist in the management and processing of nursing data, information and knowledge to
support the practice of nursing and the delivery of nursing care especially in cancer care. However aim of this study is applications of
nursing informatics in quality improvement of cancer care. Method and material: Multiple databases of scientific contents were
explored in order to assess the presence of nursing informatics or conceptually related terms. The databases were Medline
(PubMed) and google scholar. Discussion: This article present application of nursing informatics in three categories. Clinical practice,
education and research in cancer management are studied fields. In addition, researchers survey impact of applications in enhancing
of cancer care. Conclusion: Nurses today are facing increasing information and complexity of data about cancer care. Nursing
informatics simplifies this complexity and manages information in neoplasm field. Furthermore this technology facilitate on time
access to accurate and complete information for best care.
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INTRODUCTION: Pancreatic solid pseudopapillary tumor (PSPT) is a rare tumor which histogenesis is still indefinitive paricularly.
PSPT shows solid and cystic growing pattern as its name indicates. It forms %1-3 of all pancreatic tumors.It is seen in young adult
females primarily , but it is also defined in males and older patients in low percentages. It is thought to be low malign potentially
because cure occurs by simple total resection .Besides the morphological and demographical characteristics of the tumor for strict
diagnosis and to predict the prognosis seems to be more important. CASE:The patient was 29 years old man. He had pain in midline
of the abdomen, the pain reflected to the back also. There was a 2.5 cm diameter solid mass in the body of pancreas by abdominal
computed tomography. Subtotal distal pancreatectomy was performed . Macroscopically ,there were two masses in the subtotal distal
pancreatectomy material, one of them was 3.4 cm diameter in the body of pancreas .It was a brilliant and grey-white solid lesion. And
the other was 0.7 cm diameter grey white solid lesion in the tail of pancreas. Microscopically, there was a tumoral proliferation which
formed pseudopapillary formations, nests , rosette-like formations in the hematoxilen and eosin sections.The tumor cells had thin
chromatin and some of the cells had groove or central small nucleol, oval or round nucleol, clear/eosinophilic cytoplasm.These cells
arranged in a row along hyalinized fibrovascular cores.
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Introduction; Sorafenib, a multitargeted oral tyrosine kinase inhibitor, prolongs the survival in patients with advanced hepatocellular
carcinoma (HCC). Common adverse reactions include skin reaction as hand and foot syndrome and rash, cardiac ischemia and/or
infarction, and hypertension. Hyperkalemia is a potentially life-threatening electrolyte disturbance that can lead to sudden death from
cardiac arhythmias. One of the frequent encountered reason for hyperkalemia is drug side- effect. We present a case of severe
hyperkalemia due to sorafenib in a patient with HCC. Case; A 35-year-old man with unresectable HCC, who is HBsAg positive, was
planned to be given sorafenib because of progressive disease after locoregional chemoembolization. In the second month of the
sorafenib treatment, he was admitted to the emergency department with a one week history of weakness and drowsiness. Serum
potassium level was 8.3 mmol/L (3.5-5.5 mmol/L) accompanied with mild elevations in liver enzymes. His electrocardiogram was
suggestive of an effect of hyperkalemia. He did not have a prior use of medication that can cause hyperkalemia. Sorafenib treatment
was stopped and emergency hemodialysis was applied for three times. After the treatment, his potassium level reduced to normal
ranges and stabilized. Conclusion; In literature, there is only one case of sorafenib induced hyperkalemia which was observed in a
patient with tumor lysis syndrome. Our case did not have other signs of tumor lysis syndrome. Besides, he was not using any other
drugs that can cause hyperkalemia and his potassium levels recovered after cessation of sorafenib which are remarkable for
sorafenib induced hyperkalemia.
P-065 PRIMARY UTERINE EWINGS SARCOMA: A VERY RARE CASE REPORT
U. Uyeturk, I. Turker, B. Budakoglu, B. Oksuzoglu, N. Zengin
Dr. Abdurrahman Yurtarslan Oncology Training and Research Hospital, 2nd Medical Oncology Department, Ankara, Turkey
Introduction:and objectives; Ewing sarcoma (ES) is the second most common malignant bone tumor after osteosarcoma. Atypical
extraskeletal ES is rare however but atypical primary sites like uterus is even rarer. Case; A seventeen-year old single women was
admitted to hospital with the complaints of vaginal bleeding. Suspected uterine myoma, she was underwent myomectomy. The
diagnosis of ES were reported. Immunohistochemical staining of the pathology specimen revealed diffuse positive staining with CD
99, neuron specific enolase (+), all others including CD10, LCA, chromogranin, EMA were negative. Staging computed tomography
(CT) of the torax and the abdomen only showed 2 cm lymphadenopaty (LAP) near iliac bifurcation in the abdomen. To confirm the
staging FDG-PET was done. Pathological FDG uptake was only seen in the intraabdominal LAP, defined in CT. NCI chemotherapy
protocol including vincristine, adriamycine, cyclophosphamide alternating with ifosfamide, etoposide was initiated. After 12th week,
she was performed laparotomy and total abdominal hysterectomy and LAP dissection were done. Pathological examination of the
operation material showed residual tumor in the obturatory lymph node and other other findings were within normal limits. She has
still having chemotherapy. Conclusion; Uterus ES is a very rare and aggressive tumor seen in women with reproductive age. Local
and distant metastases are commonly seen. Early diagnosis and treatment is important in achieving high cure rates. Multimodality
